Poster presented at the 2025 American Association of Cancer Research Annual Meeting
Presentations
This is some text inside of a div block.
April 29, 2025
Related announcements
Iambic Therapeutics Announces the Addition of Shalini Sharp to its Board of Directors
Iambic Therapeutics Announces the Addition of Shalini Sharp to its Board of Directors
Iambic to Present New Pre-Clinical NSCLC Data for IAM1363, a Selective Type II Inhibitor for HER2 Cancers, at the 2025 World Conference on Lung Cancer
